<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yun JS</submitter><funding>Hollings Cancer Center, Medical University of South Carolina</funding><funding>Ministry of Science ICT and Future Planning</funding><funding>NIBIB NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Research Foundation of Korea</funding><funding>NIGMS NIH HHS</funding><pagination>89-95</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6145842</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>504(1)</volume><pubmed_abstract>The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5'-3' exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3'-NADP&lt;sup>+&lt;/sup>. Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3', 5'-bisphosphate (pAp), a known inhibitor of the 5'-3' exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO-pAp-Mg&lt;sup>2+&lt;/sup> complex at 1.8 Å</pubmed_abstract><journal>Biochemical and biophysical research communications</journal><pubmed_title>Molecular mechanism for the inhibition of DXO by adenosine 3',5'-bisphosphate.</pubmed_title><pmcid>PMC6145842</pmcid><funding_grant_id>2016R1C1B2009691</funding_grant_id><funding_grant_id>R35 GM118093</funding_grant_id><funding_grant_id>GM118093</funding_grant_id><funding_grant_id>P30 EB009998</funding_grant_id><funding_grant_id>2013R1A1A1061391</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Chang JH</pubmed_authors><pubmed_authors>Yun JS</pubmed_authors><pubmed_authors>Tong L</pubmed_authors><pubmed_authors>Choi YJ</pubmed_authors><pubmed_authors>Yoon JH</pubmed_authors><pubmed_authors>Son YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular mechanism for the inhibition of DXO by adenosine 3',5'-bisphosphate.</name><description>The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5'-3' exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3'-NADP&lt;sup>+&lt;/sup>. Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3', 5'-bisphosphate (pAp), a known inhibitor of the 5'-3' exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO-pAp-Mg&lt;sup>2+&lt;/sup> complex at 1.8 Å</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2025-06-01T03:31:42.967Z</modification><creation>2019-10-11T07:16:16Z</creation></dates><accession>S-EPMC6145842</accession><cross_references><pubmed>30180947</pubmed><doi>10.1016/j.bbrc.2018.08.135</doi></cross_references></HashMap>